Resultados de la búsqueda 171-180 of 19071 for Two-phase

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

  5. Hematología - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  6. Diagnósticos y tratamientos - Mayo Clinic

    A stage 2 T-cell lymphoma involves two or more lymph node regions on the same side of the diaphragm. Stage 3 T-cell lymphoma. A stage 3 T-cell lymphoma ...

  7. Oncología (médica) - Ensayos clínicos

    The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort and phase II ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    In Part 2 Cohort 2, a safety run in and expansion phase will be undertaken with Q901 at the RP2D administered in combination with pembrolizumab (400 mg Q6W) ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...